Skip to main content
Caplight Logo









Kinvent

Kinvent

Private
MontpellierHealthcare & Life Scienceshttps://kinvent.com/

Last Round

Series B

Jan 18, 2024

Total Funding Raised

$25.3M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Kinvent is a monitoring equipment company that develops a sensor-based device intended to monitor athletic movements and enhance physical rehabilitation and sports biomechanics.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sports & Fitness, Vertical SaaS, Sensors

Business Model

B2B

Customer Profile

Hardware + Subscription

AI Layer

Application

Keywords

rehabilitation technologyphysiotechrehab techconnected sensorsphysical therapy technologysports techbiomechanics platformstrength testingobjective measurementsports performance technologydynamometerforce plateshuman performancemovement analysisbiofeedback systemwearable sensorsgoniometersurface EMGpose detection

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kinvent Comparables

Compare Kinvent with similar companies based on industry and business-model similarity.

Kinvent comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Strength By Numbers
84%
VALD
83%
Meloq
79%

Kinvent Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJan 18, 2024
Series ADec 2, 2021

Key People

Founding team and executive leadership

Athanase Kollias

CEO

Executive Team

Kinvent Investors

Notable investors and investment history

Kinvent investors
InvestorRounds
SofilaroSeries A, Series B
Uni.FundSeries A, Series B, Seed
Les Business Angels des Grandes EcolesSeries A, Series B, Seed
BpifranceSeries A
EurazeoSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Open roles increased to 31, 3.2x the trailing average.

  • Jul 13, 2026

    Open roles increased to 21, 23% of headcount.

Kinvent Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Kinvent Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kinvent's valuation, stock price, and market status.

Firmographic Details

HeadquartersMontpellier
Employee Range92
Year Founded2017
Last FundingJan 18, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?